Back to search

Article

Safety and immunopotency of an adenovirus-vectored tuberculosis vaccine delivered via inhaled aerosol to healthy humans: a dose and route comparison phase 1b study

2021-09-14

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> Adenoviral (Ad)-vectored vaccines are typically administered via intramuscular injection to humans, but this route of delivery is unable to induce respiratory mucosal immunity which requires respiratory mucosal route of vaccination. However, inhaled aerosol delivery of Ad-vectored vaccines has remained poorly characterized and its ability to induce respiratory mucosal immunity...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2d4b794c-541c-5796-af10-cd4c09255910
DOI
10.1101/2021.09.09.21263339
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety and immunopotency of an adenovirus-vectored tuberculosis vaccine delivered via inhaled aerosol to healthy humans: a dose and route comparison phase 1b studyDOI 10.1101/2021.09.09.21263339
Select a neighboring publication to make it the new centre.